MYRIAD GENETICS INC cotiza a 4.08 USD y tiene una capitalización bursátil de $390M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germli…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.25 | $-0.09 | $0.04 |
| Estimado | $-0.20 | $-0.06 | $-0.07 | $-0.02 |
| Sorpresa | — | -316.7% | -28.6% | +300.0% |
| Métrica | MYGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 69.9% | 57.0% | +12.9% |
| Operating Margin | -47.0% | -38.6% | -8.3% |
| Net Margin | -44.4% | -33.6% | -10.8% |
| FCF Margin | — | -13.9% | — |
| ROE | -99.4% | -40.4% | -59.0% |
| ROA | -51.8% | -32.0% | -19.8% |
| Current Ratio | 2.49 | 2.84 | -0.35 |
| Debt / Equity | 0.33 | 0.28 | +0.05 |